VA HB342 | 2024 | Regular Session
Status
Completed Legislative Action
Spectrum: Partisan Bill (Democrat 1-0)
Status: Passed on April 4 2024 - 100% progression
Action: 2024-04-04 - Governor: Acts of Assembly Chapter text (CHAP0440)
Text: Latest bill text (Chaptered) [HTML]
Spectrum: Partisan Bill (Democrat 1-0)
Status: Passed on April 4 2024 - 100% progression
Action: 2024-04-04 - Governor: Acts of Assembly Chapter text (CHAP0440)
Text: Latest bill text (Chaptered) [HTML]
Summary
Naloxone or other opioid antagonists; possession and administration by state agencies. Requires state agencies to possess naloxone or other opioid antagonists used for overdose reversal to a person who is believed to be experiencing or about to experience a life-threatening opioid overdose and permits employees of any state agency to possess and administer naloxone or other opioid antagonists. The bill also directs the Department of Health to post on its website informational resources relating to the use of naloxone and other opioid antagonists for opioid overdose reversal and prevention in public places. Finally, the bill directs the Department of Health to develop a plan for the procurement and distribution of naloxone or other opioid antagonists to each state agency and for the possession of naloxone or other opioid antagonists by each state agency and to report its progress in developing such plan to the Governor and the Chairmen of the House Committee on Health and Human Services and the Senate Committee on Education and Health by November 1, 2024. Naloxone or other opioid antagonists; possession and administration by state agencies. Requires state agencies to possess naloxone or other opioid antagonists used for overdose reversal to a person who is believed to be experiencing or about to experience a life-threatening opioid overdose and permits employees of any state agency to possess and administer naloxone or other opioid antagonists. The bill also directs the Department of Health to post on its website informational resources relating to the use of naloxone and other opioid antagonists for opioid overdose reversal and prevention in public places. Finally, the bill directs the Department of Health to develop a plan for the procurement and distribution of naloxone or other opioid antagonists to each state agency and for the possession of naloxone or other opioid antagonists by each state agency and to report its progress in developing such plan to the Governor and the Chairmen of the House Committee on Health and Human Services and the Senate Committee on Education and Health by November 1, 2024.
Title
Naloxone or other opioid antagonists; possession by state agencies, guidelines for private employer.
Sponsors
Roll Calls
2024-03-08 - House - House: VOTE: Adoption (95-Y 0-N) (Y: 95 N: 0 NV: 0 Abs: 5) [PASS]
2024-03-08 - Senate - Senate: Conference report agreed to by Senate (40-Y 0-N) (Y: 40 N: 0 NV: 0 Abs: 0) [PASS]
2024-03-07 - Senate - Senate: Senate insisted on substitute (40-Y 0-N) (Y: 40 N: 0 NV: 0 Abs: 0) [PASS]
2024-03-07 - House - House: VOTE: REJECTED (0-Y 99-N) (Y: 0 N: 99 NV: 0 Abs: 1) [FAIL]
2024-03-06 - Senate - Senate: Passed Senate with substitute (40-Y 0-N) (Y: 40 N: 0 NV: 0 Abs: 0) [PASS]
2024-03-05 - Senate - Senate: Constitutional reading dispensed (39-Y 0-N) (Y: 39 N: 0 NV: 0 Abs: 1) [PASS]
2024-03-04 - Senate - Senate: Reported from Finance and Appropriations with substitute (15-Y 0-N) (Y: 15 N: 0 NV: 0 Abs: 0) [PASS]
2024-02-29 - Senate - Senate: Reported from Education and Health (15-Y 0-N) (Y: 15 N: 0 NV: 0 Abs: 0) [PASS]
2024-02-12 - House - House: VOTE: Block Vote Passage (100-Y 0-N) (Y: 100 N: 0 NV: 0 Abs: 0) [PASS]
2024-02-06 - House - House: Reported from Health and Human Services with substitute (22-Y 0-N) (Y: 22 N: 0 NV: 0 Abs: 0) [PASS]
2024-02-01 - House - House: Subcommittee recommends reporting with substitute (8-Y 0-N) (Y: 8 N: 0 NV: 0 Abs: 0) [PASS]
2024-03-08 - Senate - Senate: Conference report agreed to by Senate (40-Y 0-N) (Y: 40 N: 0 NV: 0 Abs: 0) [PASS]
2024-03-07 - Senate - Senate: Senate insisted on substitute (40-Y 0-N) (Y: 40 N: 0 NV: 0 Abs: 0) [PASS]
2024-03-07 - House - House: VOTE: REJECTED (0-Y 99-N) (Y: 0 N: 99 NV: 0 Abs: 1) [FAIL]
2024-03-06 - Senate - Senate: Passed Senate with substitute (40-Y 0-N) (Y: 40 N: 0 NV: 0 Abs: 0) [PASS]
2024-03-05 - Senate - Senate: Constitutional reading dispensed (39-Y 0-N) (Y: 39 N: 0 NV: 0 Abs: 1) [PASS]
2024-03-04 - Senate - Senate: Reported from Finance and Appropriations with substitute (15-Y 0-N) (Y: 15 N: 0 NV: 0 Abs: 0) [PASS]
2024-02-29 - Senate - Senate: Reported from Education and Health (15-Y 0-N) (Y: 15 N: 0 NV: 0 Abs: 0) [PASS]
2024-02-12 - House - House: VOTE: Block Vote Passage (100-Y 0-N) (Y: 100 N: 0 NV: 0 Abs: 0) [PASS]
2024-02-06 - House - House: Reported from Health and Human Services with substitute (22-Y 0-N) (Y: 22 N: 0 NV: 0 Abs: 0) [PASS]
2024-02-01 - House - House: Subcommittee recommends reporting with substitute (8-Y 0-N) (Y: 8 N: 0 NV: 0 Abs: 0) [PASS]
History
Date | Chamber | Action |
---|---|---|
2024-04-04 | Governor: Acts of Assembly Chapter text (CHAP0440) | |
2024-04-04 | Governor: Approved by Governor-Chapter 440 (effective 7/1/24) | |
2024-03-27 | Governor: Governor's Action Deadline 11:59 p.m., April 8, 2024 | |
2024-03-27 | House | Enrolled Bill communicated to Governor on March 27, 2024 |
2024-03-26 | House | Signed by Speaker |
2024-03-25 | Senate | Signed by President |
2024-03-25 | House | Bill text as passed House and Senate (HB342ER) |
2024-03-25 | House | Enrolled |
2024-03-08 | House | VOTE: Adoption (95-Y 0-N) |
2024-03-08 | House | Conference report agreed to by House (95-Y 0-N) |
2024-03-08 | Senate | Conference report agreed to by Senate (40-Y 0-N) |
2024-03-08 | House | Conference substitute printed 24109115D-H2 |
2024-03-08 | Conference: Amended by conference committee | |
2024-03-07 | House | Delegates: Hope, Shin, Higgins |
2024-03-07 | House | Conferees appointed by House |
2024-03-07 | Senate | Senators: Favola, Aird, Head |
2024-03-07 | Senate | Conferees appointed by Senate |
2024-03-07 | House | House acceded to request |
2024-03-07 | Senate | Senate requested conference committee |
2024-03-07 | Senate | Senate insisted on substitute (40-Y 0-N) |
2024-03-07 | House | VOTE: REJECTED (0-Y 99-N) |
2024-03-07 | House | Senate substitute rejected by House 24108846D-S1 (0-Y 99-N) |
2024-03-06 | Senate | Passed Senate with substitute (40-Y 0-N) |
2024-03-06 | Senate | Engrossed by Senate - committee substitute HB342S1 |
2024-03-06 | Senate | Committee substitute agreed to 24108846D-S1 |
2024-03-06 | Senate | Reading of substitute waived |
2024-03-06 | Senate | Read third time |
2024-03-05 | Senate | Constitutional reading dispensed (39-Y 0-N) |
2024-03-04 | Senate | Committee substitute printed 24108846D-S1 |
2024-03-04 | Senate | Reported from Finance and Appropriations with substitute (15-Y 0-N) |
2024-02-29 | Senate | Rereferred to Finance and Appropriations |
2024-02-29 | Senate | Reported from Education and Health (15-Y 0-N) |
2024-02-21 | Senate | Assigned Education and Health Sub: Health Professions |
2024-02-13 | Senate | Referred to Committee on Education and Health |
2024-02-13 | Senate | Constitutional reading dispensed |
2024-02-12 | House | VOTE: Block Vote Passage (100-Y 0-N) |
2024-02-12 | House | Read third time and passed House BLOCK VOTE (100-Y 0-N) |
2024-02-09 | House | Engrossed by House - committee substitute HB342H1 |
2024-02-09 | House | Committee substitute agreed to 24106801D-H1 |
2024-02-09 | House | Read second time |
2024-02-08 | House | Read first time |
2024-02-06 | House | Committee substitute printed 24106801D-H1 |
2024-02-06 | House | Reported from Health and Human Services with substitute (22-Y 0-N) |
2024-02-01 | House | Subcommittee recommends referring to Committee on Appropriations |
2024-02-01 | House | Subcommittee recommends reporting with substitute (8-Y 0-N) |
2024-01-17 | House | Assigned sub: Health |
2024-01-05 | House | Referred to Committee on Health and Human Services |
2024-01-05 | House | Prefiled and ordered printed; offered 01/10/24 24100674D |
Subjects
Administration of Government
Opioids
Professions and Occupations
State Agencies
Study Commissions Committees and Reports
Opioids
Professions and Occupations
State Agencies
Study Commissions Committees and Reports